相关实验视频
Updated: Jun 10, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.1K
在有月经前易怒和愤怒的妇女中,间歇性埃斯基塔洛普拉姆治疗和反应性侵略:一个交叉研究
Maria Gröndal1, Jakob Näslund2, Christin Englund2
1Department of Psychology, University of Gothenburg, Sweden.
Journal of affective disorders
|October 11, 2024
概括
选择性血清素再吸收抑制剂 (SSRI) 降低了女性的易怒和愤怒. 埃斯基塔洛普拉姆药物对反应性侵略产生了多种影响,突出了个体症状表现的差异.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 是治疗月经前情绪症状的主要治疗方法.
- 兴奋剂在减少反应性攻击性,易怒和愤怒方面是有效的.
- 这项研究研究了埃斯基塔洛普拉姆对前经期易怒/愤怒的女性反应性侵略的实验室测量效应.
研究的目的:
- 在实验室测量反应性侵略时检查埃斯基塔洛普拉姆对行为反应的影响.
- 评估埃斯基塔洛普拉姆对月经前易怒和愤怒症状的影响.
- 探索愤怒表达的个体差异及其与治疗反应的关系.
主要方法:
- 34名参与者对三个周期的月经前失调障碍症状进行了评分.
- 一个单盲的交叉设计,使用埃斯基塔洛普拉姆 (20毫克) 或安慰剂.
- 攻击性任务 (AI-UG,PSAP) 和愤怒表达/控制等级 (STAXI-2) 在色和卵泡阶段进行.
主要成果:
- 与安慰剂相比,在埃斯基塔洛普拉姆循环期间,易怒/愤怒症状减少.
- 在点减去侵略范式 (PSAP) 中没有观察到埃斯基塔洛普拉姆的显著影响.
- 在一组具有特定愤怒表达模式的参与者中,埃斯基塔洛普拉姆在愤怒注入的终极游戏 (AI-UG) 中降低了反应性攻击性.
结论:
- 埃斯基塔洛普拉姆对反应性侵略的影响是可变的,并且取决于个人的月经前愤怒表达模式.
- 传统的侵略措施可能无法完全捕捉严重的月经前刺激/愤怒的行为影响.
- 症状表现的个体差异对于理解月经前情绪障碍治疗结果至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
197
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
322
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
322
Electroconvulsive Therapy
26
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
26
Rational Emotive Behavior Therapy
43
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
43
Mania and Antimanic Drugs: Overview
138
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
138
Drugs for Treatment of Diarrhea-Predominant IBS
151
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
151

